Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ele Ferrannini

Showing results (211-220 of 408) with videos related to

Pageof 41
Sort By:
European Heart Journal|February 5, 2005
Haematocrit, type 2 diabetes, and endothelium-dependent vasodilatation of resistance vesselsAndrea Natali, Elena Toschi, Stephanie Baldeweg, et al.
American Journal of Physiology. Endocrinology and Metabolism|June 18, 2009
Improved tolerance to sequential glucose loading (Staub-Traugott effect): size and mechanismsSandra Bonuccelli, Elza Muscelli, Amalia Gastaldelli, et al.
American Journal of Physiology. Endocrinology and Metabolism|June 2, 2016
Glucose uptake saturation explains glucose kinetics profiles measured by different testsRoberto Bizzotto, Andrea Natali, Amalia Gastaldelli, et al.
Endocrinology, Diabetes & Metabolism|March 1, 2019
Slope of change in HbA<sub>1c</sub> from baseline with empagliflozin compared with sitagliptin or glimepiride in patients with type 2 diabetesRalph A DeFronzo, Ele Ferrannini, Guntram Schernthaner, et al.
Salud Publica De Mexico|April 10, 2014
Sweetened beverages intake, hyperuricemia and metabolic syndrome: the Mexico City Diabetes StudyRubén López-Molina, Socorro Parra-Cabrera, Ruy López-Ridaura, et al.
The Journal of Clinical Investigation|January 28, 2014
Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patientsEle Ferrannini, Elza Muscelli, Silvia Frascerra, et al.
Diabetes|May 28, 2011
Body weight, not insulin sensitivity or secretion, may predict spontaneous weight changes in nondiabetic and prediabetic subjects: the RISC studyEleni Rebelos, Elza Muscelli, Andrea Natali, et al.
American Journal of Physiology. Endocrinology and Metabolism|February 16, 2006
Impact of incretin hormones on beta-cell function in subjects with normal or impaired glucose toleranceElza Muscelli, Andrea Mari, Andrea Natali, et al.
Diabetes Care|January 1, 2008
Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: update regarding thiazolidinediones: a consensus statement from the American Diabetes Association and the European Association for the Study of DiabetesDavid M Nathan, John B Buse, Mayer B Davidson, et al.
Diabetes Care|October 24, 2008
Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of DiabetesDavid M Nathan, John B Buse, Mayer B Davidson, et al.
Pageof 41

Showing results (211-220 of 408) with videos related to

Sort By:
Pageof 41
European Heart Journal|February 5, 2005
Haematocrit, type 2 diabetes, and endothelium-dependent vasodilatation of resistance vesselsAndrea Natali, Elena Toschi, Stephanie Baldeweg, et al.
American Journal of Physiology. Endocrinology and Metabolism|June 18, 2009
Improved tolerance to sequential glucose loading (Staub-Traugott effect): size and mechanismsSandra Bonuccelli, Elza Muscelli, Amalia Gastaldelli, et al.
American Journal of Physiology. Endocrinology and Metabolism|June 2, 2016
Glucose uptake saturation explains glucose kinetics profiles measured by different testsRoberto Bizzotto, Andrea Natali, Amalia Gastaldelli, et al.
Endocrinology, Diabetes & Metabolism|March 1, 2019
Slope of change in HbA<sub>1c</sub> from baseline with empagliflozin compared with sitagliptin or glimepiride in patients with type 2 diabetesRalph A DeFronzo, Ele Ferrannini, Guntram Schernthaner, et al.
Salud Publica De Mexico|April 10, 2014
Sweetened beverages intake, hyperuricemia and metabolic syndrome: the Mexico City Diabetes StudyRubén López-Molina, Socorro Parra-Cabrera, Ruy López-Ridaura, et al.
The Journal of Clinical Investigation|January 28, 2014
Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patientsEle Ferrannini, Elza Muscelli, Silvia Frascerra, et al.
Diabetes|May 28, 2011
Body weight, not insulin sensitivity or secretion, may predict spontaneous weight changes in nondiabetic and prediabetic subjects: the RISC studyEleni Rebelos, Elza Muscelli, Andrea Natali, et al.
American Journal of Physiology. Endocrinology and Metabolism|February 16, 2006
Impact of incretin hormones on beta-cell function in subjects with normal or impaired glucose toleranceElza Muscelli, Andrea Mari, Andrea Natali, et al.
Diabetes Care|January 1, 2008
Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: update regarding thiazolidinediones: a consensus statement from the American Diabetes Association and the European Association for the Study of DiabetesDavid M Nathan, John B Buse, Mayer B Davidson, et al.
Diabetes Care|October 24, 2008
Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of DiabetesDavid M Nathan, John B Buse, Mayer B Davidson, et al.
Pageof 41